Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Fibrolamellar carcinoma has a distinctive morphology and immunophenotype, including cytokeratin 7 and CD68 co-expression. Despite the distinct findings, accurate diagnosis of fibrolamellar carcinoma continues to be a challenge. Recently, fibrolamellar carcinomas were found to harbor a characteristic...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, Rondell P, Yeh, Matthew M, Lam-Himlin, Dora, Roberts, Lewis R, Terracciano, Luigi, Cruise, Michael W, Greipp, Patricia T, Zreik, Riyam T, Jain, Dhanpat, Zaid, Nida, Salaria, Safia N, Jin, Long, Wang, Xiaoke, Rustin, Jeanette G, Kerr, Sarah E, Sukov, William R, Solomon, David A, Kakar, Sanjay, Waterhouse, Emily, Gill, Ryan M, Ferrell, Linda, Alves, Venancio AF, Nart, Deniz, Yilmaz, Funda, Roessler, Stephanie, Longerich, Thomas, Schirmacher, Peter, Torbenson, Michael S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758901/
https://www.ncbi.nlm.nih.gov/pubmed/28862261
http://dx.doi.org/10.1038/modpathol.2017.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758901/
https://www.ncbi.nlm.nih.gov/pubmed/28862261
http://dx.doi.org/10.1038/modpathol.2017.103

Ejemplares similares